Paloma Partners’s Adient ADNT Stock Holding History

Paloma Partners’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-115,200	Closed	-$3.41M	–	983
2022 Q2	$3.41M	Buy	+115,200	New	+$3.87M	0.12%	161

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Paloma Partners's ADNT Position: Q1 2021 in Review

Paloma Partners sold out of Adient (ADNT) in Q1 2021, closing a stake of 9,122 shares — an estimated $317K sold.

Paloma Partners first reported a position in ADNT in Q3 2017 and held it in 10 quarters. The position peaked at $1.8M in Q3 2018. 300 funds tracked by Wall St. Rank hold ADNT as of Q1 2021.

Paloma Partners reported no remaining Adient position as of Q1 2021 after selling out during the quarter.
Paloma Partners sold 9,122 Adient shares in Q1 2021, an estimated $317K.
Paloma Partners first reported a position in Adient in Q3 2017 and held it in 10 quarters.
Paloma Partners's Adient position peaked at $1.8M in Q3 2018.
300 funds tracked by Wall St. Rank held Adient as of Q1 2021.

Based on Paloma Partners's 13F filing for Q1 2021, filed 17 May 2021.